Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Therapy Name | PTX-35 |
Synonyms | |
Therapy Description |
PTX-35 is a humanized monoclonal agonistic antibody that targets TNFRSF25, which may stimulate anti-tumor immune response (PMID: 31694725). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
PTX-35 | PTX-35 is a humanized monoclonal agonistic antibody that targets TNFRSF25, which may stimulate anti-tumor immune response (PMID: 31694725). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT04430348 | Phase I | PTX-35 | PTX-35 in Patients With Advanced Solid Tumors | Terminated | USA | 0 |